1. Historical Background and Development of the Profession of Pharmacy
Pharmacy is a healthcare profession focused on the safe and effective use of medications. Its rich history spans ancient civilizations to modern scientific advancements, continually evolving to meet societal health needs.
1.1. History of Profession of Pharmacy in India
The journey of pharmacy in India is a fascinating blend of traditional practices and modern scientific integration. Historically, India relied on indigenous systems like Ayurveda, Unani, and Siddha, where Vaidyas and Hakims prepared medicines. The formalization of the profession began with British influence and accelerated post-independence.
| Era/Aspect | Key Developments & Impact |
|---|---|
| Ancient & Medieval India | Dominance of traditional systems (Ayurveda, Unani, Siddha). Medicines prepared by practitioners themselves. Emphasis on natural products. |
| British Rule (17th-19th Century) | Introduction of Western medicine. Establishment of government dispensaries and hospitals. Limited role for pharmacists; doctors often dispensed. First chemist shops emerged in major cities like Kolkata and Mumbai. |
| Early 20th Century (Pre-Independence) | Growing need for standardized drug manufacturing and dispensing. Demand for trained pharmacists. Formation of Indian Pharmaceutical Association (IPA) in 1935. Recommendations for pharmacy education. |
| Pharmacy Education | First formal pharmacy diploma course in 1932 at Andhra University (Waltair) and Banaras Hindu University. Establishment of more institutions post-independence. Development of B.Pharm and M.Pharm programs. Regulatory bodies like Pharmacy Council of India (PCI) established. |
| Pharmaceutical Industry | Initial reliance on imports. Emergence of indigenous companies (e.g., Alembic, Bengal Chemicals) for basic drug production. Significant growth post-1970 with the Indian Patent Act, focusing on reverse engineering and generic drug production. Today, India is a global leader in generic drugs and vaccine production. |
| Pharmacy Organizations & Regulation | Pharmacy Council of India (PCI): Established under the Pharmacy Act, 1948, to regulate pharmacy education and practice. Registers pharmacists. Drug Controller General of India (DCGI): Regulates drug manufacturing, sales, and quality. Indian Pharmaceutical Association (IPA): Promotes interests of pharmacists. All India Organisation of Chemists and Druggists (AIOCD): Represents retail and wholesale pharmacists. |
| Current Scenario | Highly regulated, globally recognized industry. Pharmacists play diverse roles in community, hospital, industry, academia, and research. Emphasis on patient counseling and clinical pharmacy. |
1.2. Pharmacy as a Career
Pharmacy offers a dynamic and rewarding career path with diverse opportunities across various sectors of healthcare and industry. It's a profession where scientific knowledge meets patient care.
Career Compass: Where Can a Pharmacist Go?
- Community Pharmacy: Dispensing, patient counseling, medication therapy management.
- Hospital Pharmacy: Ward rounds, drug information, compounding, sterile preparations.
- Pharmaceutical Industry: R&D, manufacturing, quality control/assurance, regulatory affairs, sales & marketing.
- Academia: Teaching, research.
- Regulatory Bodies: Drug inspection, policy making (e.g., PCI, CDSCO).
- Clinical Research: Clinical trials, pharmacovigilance.
- Government: Drug testing labs, armed forces.
2. Pharmacopoeias
A Pharmacopoeia is an official compilation of standards for drug substances and pharmaceutical preparations. It includes monographs for the identification, purity, strength, and quality of medicines, ensuring consistency and safety across different manufacturers.
These authoritative texts are crucial for maintaining the quality of medicines and are legally recognized in their respective countries or regions.
| Pharmacopoeia | Description & Key Features | Origin & Abbreviation |
|---|---|---|
| Indian Pharmacopoeia | Official book of standards for drugs manufactured and marketed in India. Published by the Indian Pharmacopoeia Commission (IPC). Ensures quality, safety, and efficacy of medicines in India. | India (IP) |
| British Pharmacopoeia | Primary reference for medicines and medicinal products used in the United Kingdom and many Commonwealth countries. Published by the Medicines and Healthcare products Regulatory Agency (MHRA). Known for its comprehensive coverage and stringent standards. | United Kingdom (BP) |
| United States Pharmacopeia | Official compendium of drug standards for the United States. Published by the United States Pharmacopeial Convention (USP). Also includes general chapters on tests and assays, and dietary supplements. | United States (USP) |
| Extra Pharmacopoeia (Martindale) | Not a true pharmacopoeia of standards, but a comprehensive international reference work on drugs and medicines. Provides unbiased, authoritative information on drugs in clinical use worldwide, including pharmacokinetics, uses, side effects, and proprietary names. | United Kingdom (Martindale) |
Remember the 'P's of Pharmacopoeias!
IP for India, BP for Britain, USP for USA.
Martindale is the 'Extra' one – it's a reference, not a set of legal standards like the others.
3. Dosage Forms
3.1. Introduction to Dosage Forms
A dosage form is the physical form in which a drug is produced and dispensed, such as a tablet, capsule, or injectable solution. It is the vehicle for drug delivery, designed to optimize drug stability, patient compliance, and most importantly, drug release and absorption. The primary goal is to ensure the drug reaches its site of action in the body in sufficient concentration and at the correct rate to elicit a therapeutic response, while minimizing adverse effects.
3.2. Classification and Definitions of Dosage Forms
Dosage forms are broadly classified based on their physical state, route of administration, and mode of release.
| Classification Criterion | Category | Examples |
|---|---|---|
| Physical State | Solid | Tablets, Capsules, Powders, Granules, Suppositories |
| Liquid | Solutions, Suspensions, Emulsions, Syrups, Elixirs | |
| Semi-Solid | Ointments, Creams, Gels, Pastes | |
| Gaseous/Aerosol | Inhalers, Nebulizers, Sprays | |
| Route of Administration | Oral | Tablets, Capsules, Syrups, Suspensions |
| Parenteral | Injections (IV, IM, SC) | |
| Topical | Ointments, Creams, Patches | |
| Rectal | Suppositories, Enemas | |
| Vaginal | Suppositories, Creams, Tablets | |
| Ophthalmic | Eye Drops, Eye Ointments | |
| Otic | Ear Drops | |
| Nasal | Nasal Sprays, Drops | |
| Inhalation | Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers | |
| Release Pattern | Immediate Release (IR) | Standard tablets, capsules, solutions |
| Extended Release (ER)/Sustained Release (SR) | Matrix tablets, Coated pellets, Osmotic pumps | |
| Delayed Release (DR) | Enteric-coated tablets/capsules | |
| Targeted Release | Liposomes, Nanoparticles, Monoclonal antibody conjugates |
3.2.1. Solid Dosage Forms
Solid dosage forms are the most common and preferred type due to their stability, accuracy of dosing, and patient convenience.
Tablets: Solid pharmaceutical dosage forms containing drug substances with or without excipients, usually prepared by compression or molding.
Capsules: Solid dosage forms in which the drug substance and/or excipients are enclosed within a soluble shell, typically made of gelatin.
Powders: Intimate mixtures of dry, finely divided drug and/or excipients. Can be bulk (e.g., antacids) or divided (e.g., antibiotic sachets).
Granules: Aggregates of powder particles, typically 2-4 mm in size, offering better flow properties and compressibility than fine powders.
Suppositories: Solid dosage forms for rectal administration, designed to melt or dissolve at body temperature, releasing the drug for local or systemic effect.
3.2.2. Liquid Dosage Forms
Liquid dosage forms are homogeneous or heterogeneous preparations intended for oral, topical, or parenteral administration.
Solutions: Homogeneous mixtures of two or more substances, where the drug (solute) is completely dissolved in a suitable solvent (e.g., water, alcohol, glycerol).
Suspensions: Heterogeneous two-phase systems consisting of finely divided solid drug particles (suspensoid) dispersed in a liquid medium, in which the drug is not soluble.
Emulsions: Heterogeneous two-phase systems consisting of two immiscible liquids, one of which is dispersed as globules (internal phase) throughout the other (external phase), stabilized by an emulsifying agent.
3.2.3. Semi-Solid Dosage Forms
Semi-solid dosage forms are intended for topical application to the skin or mucous membranes.
Ointments: Semi-solid preparations for external application to the skin or mucous membranes, typically consisting of an oleaginous (fatty) base, known for their occlusivity.
Creams: Semi-solid emulsions (O/W or W/O) that are softer and more elegant than ointments, allowing for easier spreading and removal.
Gels: Semi-solid systems consisting of a dispersion of small or large molecules in an aqueous liquid vehicle, rendered semi-solid by a gelling agent.
3.2.4. Sterile Dosage Forms
Sterile dosage forms are free from viable microorganisms and pyrogens, critical for routes like injection or application to sensitive areas.
Parenterals (Injections): Sterile preparations intended for administration by injection through one or more layers of skin or mucous membranes.
Ophthalmic Preparations: Sterile solutions, suspensions, or ointments applied to the eye, requiring strict isotonicity and non-irritating properties.
4. Prescription
4.1. Definition of a Prescription
A Prescription is a written order from a registered medical practitioner (doctor, dentist, veterinarian, etc.) to a pharmacist for the preparation and dispensing of a specific medication to an individual patient.
It is a vital legal document and a critical communication tool between the prescriber and the pharmacist, ensuring safe and effective medication use.
4.2. Parts of a Prescription
A complete prescription typically consists of several well-defined parts, each carrying crucial information.
| Part No. | Component | Description & Importance | Example |
|---|---|---|---|
| 1 | Date | When the prescription was written. Important for legality, refilling, and stability of dispensed medication. | 01/01/2024 |
| 2 | Patient Information | Name, age, sex, and address of the patient. Essential for patient identification and dose calculations (especially for pediatric/geriatric patients). | Mr. John Doe, 45y, M, 123 Main St. |
| 3 | Superscription (Rx Symbol) | Symbol 'Rx' (from Latin 'Recipe' meaning 'take thou'). Invocation to Jupiter (God of Healing) or simply a direction to the pharmacist. | Rx |
| 4 | Inscription | Contains the name of the drug, its strength, and quantity. This is the core of the prescription. | Amoxicillin 500 mg tablets |
| 5 | Subscription | Directions to the pharmacist on how to prepare the medication (e.g., compound, mix, dispense number of units). | Disp. # 20 (Dispense 20 tablets) |
| 6 | Signatura (Sig.) | Directions to the patient regarding the dose, route, frequency, and duration of administration. This should be clear and unambiguous. | Take one tablet by mouth twice daily for 10 days. (Bid p.o. x 10 days) |
| 7 | Refill Information | Indicates if and how many times the prescription can be refilled. | Refills: 1 (or No Refills) |
| 8 | Prescriber Information | Name, address, contact number, registration number, and signature of the prescriber. Legally validates the prescription. | Dr. A. B. C. (MD), Reg. No. 12345, Signature |
| 9 | Special Instructions/Warnings | Any additional warnings or specific instructions (e.g., 'Take with food', 'Shake well before use'). | May cause drowsiness. |
4.3. Handling of Prescription
Proper prescription handling is crucial for patient safety and efficient pharmacy operations.
- Receiving the Prescription: Greet the patient, receive the prescription calmly.
- Review and Scrutiny: Carefully read the entire prescription. Check for legibility, completeness, potential errors, drug interactions, allergies, and appropriate dosing.
- Clarification: If any part is unclear or raises concerns, contact the prescriber for clarification. Never guess.
- Processing: Enter prescription details into the pharmacy system. Select the correct drug, strength, and quantity.
- Dispensing: Retrieve the medication, count/measure it accurately, and place it in an appropriate container.
- Labeling: Prepare a clear, concise, and accurate label including patient name, drug name, strength, dosage instructions, date, pharmacy name, and any auxiliary labels (e.g., 'Take with food', 'Shake well').
- Final Check: Before handing over, double-check everything – drug, label, patient.
- Patient Counseling: Explain to the patient how to take the medication, what to expect, potential side effects, and answer any questions.
- Documentation: File the prescription (physical or electronic) as per legal requirements.
4.4. Errors in Prescription
Prescription errors are a significant cause of medication-related harm. Pharmacists play a critical role in intercepting and preventing these errors.
| Type of Error | Description | Example | Prevention Strategy |
|---|---|---|---|
| Prescribing Errors | Errors occurring during the writing of the prescription by the prescriber. | Wrong drug, wrong dose, wrong route, drug allergy, drug interaction, incomplete prescription. | Careful review by pharmacist, clear communication with prescriber, electronic prescribing systems. |
| Dispensing Errors | Errors occurring during the preparation and dispensing of the medication by the pharmacy staff. | Dispensing wrong drug/strength, wrong quantity, incorrect label, wrong patient. | Strict adherence to dispensing protocols, double-checking, barcode scanning, patient counseling. |
| Administration Errors | Errors occurring when the patient (or caregiver) takes the medication. | Taking incorrect dose, wrong frequency, wrong route, omitting doses. | Clear patient counseling, simple dosage instructions, auxiliary labels, reminder systems. |
| Monitoring Errors | Failure to monitor for adverse effects or therapeutic outcomes. | Not checking blood levels for narrow therapeutic index drugs. | Pharmacist-led medication therapy management, patient education on warning signs. |
| Illegibility | Poor handwriting making the drug name or dosage unclear. | 'Lanoxin' vs 'Levoxin'; 'q.d.' vs 'q.i.d.' | Electronic prescribing, clarification with prescriber. |
| Ambiguity | Unclear or confusing instructions. | 'Take as directed' without specific details; '1 tablet daily' (when?). | Pharmacist clarification, standardized abbreviations. |
| Look-Alike, Sound-Alike (LASA) Drugs | Confusing drugs with similar names or appearances. | Celebrex vs Celexa; Hydralazine vs Hydroxyzine. | Tall Man lettering, pharmacy software alerts, physical separation in shelves. |
The Pharmacist's Mantra for Prescriptions:
Clarify: If in doubt, ask.
Accuracy: Double-check everything.
Review: For interactions, allergies, appropriateness.
Educate: Counsel the patient thoroughly.
5. Posology
5.1. Definition of Posology
Posology is the scientific study of drug dosage. It deals with the quantity of a drug that can be administered to a patient to produce a desired therapeutic effect, taking into account various factors that influence drug response.
Essentially, it's about determining the optimal dose for an individual patient, balancing efficacy and safety. The correct dosage is critical because both under-dosing (leading to lack of therapeutic effect) and over-dosing (leading to toxicity) can have serious consequences.
5.2. Factors Influencing Drug Dosage
Numerous factors can alter a patient's response to a drug, necessitating individualization of dosage. Understanding these factors is fundamental to safe and effective medication management.
| Factor | Description & Impact on Dosage |
|---|---|
| Age | Pediatric Patients: Immature organ systems (liver, kidneys) lead to altered absorption, distribution, metabolism, and excretion (ADME). Doses are often calculated based on body weight or surface area. Geriatric Patients: Age-related physiological decline (reduced renal/hepatic function, decreased body water, increased fat) often requires lower doses to prevent accumulation and toxicity. |
| Body Weight | Most drug dosages are initially based on a standard adult body weight (e.g., 70 kg). For drugs with a narrow therapeutic index, or in very lean/obese individuals, doses may be adjusted per kg of body weight to achieve target concentrations. |
| Body Surface Area (BSA) | Often used for drugs with a narrow therapeutic index, particularly in oncology and pediatrics. BSA correlates better with physiological parameters than weight alone and can provide more accurate dosing. |
| Sex | Differences in body composition (e.g., fat-to-muscle ratio), hormonal influences, and organ sizes can influence drug pharmacokinetics and pharmacodynamics. Some drugs may require dose adjustments based on sex. |
| Route of Administration | The route significantly impacts bioavailability. Intravenous (IV) drugs have 100% bioavailability, requiring lower doses compared to oral (PO) drugs which undergo first-pass metabolism and incomplete absorption. |
| Time of Administration | For some drugs, the timing relative to meals (e.g., with food to reduce GI upset or without food for better absorption) or time of day (e.g., hypnotics at night) can affect efficacy or reduce side effects. |
| Pathological State/Disease | Renal Impairment: Reduced kidney function impairs drug excretion, leading to accumulation. Doses of renally excreted drugs must be reduced. Hepatic Impairment: Liver disease impairs drug metabolism. Doses of hepatically metabolized drugs may need reduction. Cardiac Failure: Can affect drug distribution and organ perfusion. Thyroid Function: Hypothyroidism can slow metabolism, hyperthyroidism can accelerate it. |
| Drug Interactions | Concomitant use of multiple drugs can alter ADME or pharmacodynamic effects, requiring dose adjustments of one or both agents. (e.g., enzyme inducers vs. enzyme inhibitors). |
| Tolerance | Repeated administration of a drug may lead to a decreased response, requiring higher doses to achieve the same effect (e.g., opioids). |
| Synergism & Potentiation | When two drugs are given together, their combined effect might be greater than the sum of their individual effects (synergism) or one drug might increase the effect of another (potentiation). |
| Presence of Food | Food can either enhance (e.g., fat-soluble vitamins) or impair (e.g., tetracyclines with dairy) drug absorption, or mitigate gastrointestinal side effects. |
| Genetic Factors | Genetic polymorphisms can affect drug-metabolizing enzymes (e.g., CYP450 enzymes) or drug transporters, leading to fast or slow metabolism and requiring individualized dosing (pharmacogenomics). |
| Psychological Factors | The placebo effect or patient expectations can influence perceived drug efficacy. |
5.3. Types of Doses
Understanding different terminologies for drug doses is crucial for clinical practice and safety.
| Type of Dose | Description | Clinical Relevance |
|---|---|---|
| Therapeutic Dose (Effective Dose) | The dose of a drug required to produce the desired therapeutic effect in a significant proportion of the population. Often referred to as ED50 (Effective Dose in 50% of population). | The primary dose range aimed for in treatment. |
| Minimum Effective Dose | The smallest dose that produces a detectable therapeutic effect. | Important for initiating therapy at the lowest possible effective dose to minimize side effects. |
| Maximum Safe Dose | The largest dose that can be administered without producing unacceptable adverse effects. | Defines the upper limit of the therapeutic range. Exceeding this increases the risk of toxicity. |
| Toxic Dose | The dose that produces adverse effects or symptoms of poisoning. Often denoted as TD50 (Toxic Dose in 50% of population). | Used to assess the safety margin of a drug. |
| Lethal Dose | The dose that causes death. Often denoted as LD50 (Lethal Dose in 50% of test animals). | Primarily used in preclinical toxicology studies to quantify acute toxicity. Not directly applicable to human dosing. |
| Loading Dose | An initial higher dose of a drug given to rapidly achieve a therapeutic concentration in the body, especially for drugs with long half-lives. | Used when immediate therapeutic effect is needed (e.g., digoxin in heart failure, antibiotics in severe infections). |
| Maintenance Dose | Subsequent doses given after a loading dose or given regularly to maintain therapeutic concentrations within the desired range. | Ensures steady-state drug levels and sustained therapeutic effect over time. |
| Prophylactic Dose | A dose given to prevent the occurrence of a disease or condition. | E.g., antibiotics before surgery to prevent infection, antimalarials when traveling. |
| Booster Dose | An additional dose of a vaccine or drug given after an initial course to maintain or renew its effectiveness. | Common in vaccination schedules to maintain immunity. |
5.4. Dosage Calculations for Special Populations
Precise dosage calculations are essential, particularly for vulnerable populations, to ensure efficacy and minimize toxicity. Many calculations rely on established formulas or nomograms.
5.4.1. Pediatric Dosage Calculation
Children are not simply small adults. Their developing physiology necessitates specific calculation methods.
| Method | Formula | Notes |
|---|---|---|
| Young's Rule | Dose = (Age in years / (Age in years + 12)) × Adult Dose | Used for children between 1 to 12 years. Less accurate for infants. |
| Clark's Rule | Dose = (Weight of child in lbs / 150 lbs) × Adult Dose OR Dose = (Weight of child in kg / 70 kg) × Adult Dose | Assumes an average adult weight of 150 lbs (or 70 kg). A common and widely used rule, but can be inaccurate for very obese or underweight children. |
| Fried's Rule | Dose = (Age in months / 150 months) × Adult Dose | Primarily used for infants under 1 year of age (up to 2 years). |
| Body Surface Area (BSA) Method | Dose = (BSA of child (m²) / 1.73 m²) × Adult Dose | Considered the most accurate method for pediatric dosing, especially for drugs with a narrow therapeutic index. 1.73 m² is the average adult BSA. |
5.4.2. Geriatric Dosage Adjustment
Elderly patients often require reduced dosages due to age-related changes in pharmacokinetics and pharmacodynamics. Renal function often declines with age, even without overt kidney disease, making creatinine clearance estimation crucial.
- Start Low and Go Slow: A fundamental principle in geriatric prescribing.
- Renal Function Assessment: Use equations like Cockcroft-Gault or MDRD/CKD-EPI to estimate glomerular filtration rate (GFR) or creatinine clearance (CrCl) to guide dose adjustments for renally excreted drugs.
- Polypharmacy: Increased risk of drug interactions and adverse effects due to multiple medications.
- Increased Sensitivity: Enhanced CNS effects and increased risk of orthostatic hypotension.
5.4.3. Dosage Adjustment in Renal and Hepatic Impairment
For patients with compromised organ function, dose adjustments are critical to prevent drug accumulation and toxicity.
- Renal Impairment: Dosage adjustments are based on the degree of renal dysfunction (e.g., mild, moderate, severe) and the drug's primary route of elimination. Many drug monographs provide specific recommendations based on CrCl or GFR values.
- Hepatic Impairment: Adjustments are more complex due to the liver's multifaceted role in metabolism and the variability of liver disease. Often, a combination of clinical assessment (e.g., Child-Pugh score) and drug-specific guidelines is used.
Posology Pointers:
1. Individualization is Key: No 'one-size-fits-all' dose.
2. Factors Matter: Age, weight, disease, route all influence dose.
3. Pediatrics/Geriatrics: Always special considerations; start low and go slow for elderly.
4. Renal/Hepatic: Impairment requires significant dose adjustments to prevent toxicity.
5. Therapeutic Index: Narrow index drugs require very precise dosing and monitoring.
Upgrade to Success Pass (₹30) to unlock downloads and printing.